INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
ER
Corporate insider

Epstein David R

DirectorCIK 0001445826

EDGAR filingsOpen in network
Disclosed transactions6
Buys / sells5 / 1
Max Insider Score37
Connections with evidence2

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
29
ER
Epstein David RDirector
AGMBAgomAb Therapeutics NV
Open-market purchase
BUY$35K
5,000 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Tempus AI, Inc.Director · Nov 4, 2026
  • Insider ofevidence
    AgomAb Therapeutics NVDirector · Oct 22, 2026
29
ER
Epstein David RDirector
AGMBAgomAb Therapeutics NV
Open-market purchase
BUY
$35K
5,000 sh
Nov 5, 2026
Nov 6, 2026
traded Nov 5, 2026
+1d
SEC FORM 4

Evidence

33
ER
Epstein David RDirector
AGMBAgomAb Therapeutics NV
Open-market purchase
BUY$34K
5,000 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC FORM 4

Evidence

10
ER
Epstein David RDirector
TEMTempus AI, Inc.
Open-market sale · 10b5-1 plan
SELL$27K
370 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

37
ER
Epstein David RDirector
AGMBAgomAb Therapeutics NV
Open-market purchase
BUY$45K
5,000 sh
Oct 21, 2026Oct 22, 2026
traded Oct 21, 2026
+1dSEC FORM 4

Evidence

37
ER
Epstein David RDirector
AGMBAgomAb Therapeutics NV
Open-market purchase
BUY$44K
5,000 sh
Oct 21, 2026Oct 22, 2026
traded Oct 21, 2026
+1dSEC FORM 4

Evidence

Data sources
SEC FORM 425m ago
HOUSE PTR25m ago
SEC 13F25m ago
ROBINHOOD CHAIN25m ago